Biocon Biologics partners Adagio Therapeutics for Covid-19 treatment
Preclinical data generated by Adagio and validated by the University of Oxford in a series of recent Cell manuscripts show that ADG20 uniquely combines potency, breadth and complete neutralisation of SARS-CoV-2 and all currently known…